Silicon Laboratories (SLAB) FY2017 results: revenue $769 million, up 10.2% on the year
Silicon Laboratories Inc. (SLAB) reported revenue of $769 million for fiscal 2017, the year ended 30 December 2017, up 10.2% on the year before. Net income was $47 million, down 23.4%, and diluted earnings per share $1.09. The figures are the company's own, from the 10-K it filed with the SEC on 30 January 2019.
Revenue
$769 million
+10.2% on the year
FY2010FY2017
Operating margin
11.1%
9.5% a year earlier
FY2010FY2017
Net income
$47 million
-23.4% on the year
FY2010FY2017
Diluted EPS
$1.09
-24.8% on the year
FY2010FY2017
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Revenue
769
698
645
+10.2%
Cost of revenue
315
276
264
+14.0%
Gross profit
454
422
381
+7.8%
Gross margin
59.1%
60.4%
59.1%
Research and development
209
200
188
+4.9%
Selling, general and administrative
160
155
160
+2.7%
Operating income
85.0
66.3
32.2
+28.2%
Operating margin
11.1%
9.5%
5.0%
Interest expense
n/a
2.6
2.8
Pre-tax income
76.9
64.5
30.3
+19.2%
Income tax
29.8
3.0
0.7
+893.0%
Effective tax rate
38.8%
4.7%
2.2%
Net income
47.1
61.5
29.6
-23.4%
Net margin
6.1%
8.8%
4.6%
Diluted EPS
$1.09
$1.45
$0.69
-24.8%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Operating cash flow
190
129
105
+47.0%
Capital expenditure
12.3
10.9
11.3
+12.1%
Free cash flow
177
118
94.2
+50.2%
Free cash flow margin
23.1%
16.9%
14.6%
Cash from investing
-374
-49.6
-49.3
Cash from financing
313
-52.3
-83.8
Depreciation and amortisation
41.9
40.5
39.0
+3.3%
Share-based compensation
44.8
39.6
42.8
+12.9%
Buybacks
n/a
40.5
71.4
Diluted shares, weighted
43m
42m
43m
+2.3%
Shares outstanding at period end
43m
42m
42m
+2.0%
Balance sheet
$ million
FY2017
FY2016
FY2015
On the year
Last 8 years
Shareholders' equity
953
827
761
+15.2%
Debt
342
72.5
77.5
+371.6%
Other liabilities
240
182
173
+31.7%
Total liabilities and equity
1,535
1,082
1,011
+41.9%
Fixed assets
128
130
131
-1.4%
Goodwill
288
276
273
+4.4%
Intangible assets
83.1
104
121
-19.7%
Investments
495
159
136
+210.8%
Cash and equivalents
269
141
114
+90.9%
Receivables
71.4
74.4
73.6
-4.1%
Inventory
73.1
59.6
53.9
+22.8%
Other assets
128
138
109
-7.8%
Total assets
1,535
1,082
1,011
+41.9%
10-K for the year ended 30 December 2017, filed 30 January 2019: the filing.